Responsive image

Common name


N-benzylbenzamide

IUPAC name


N-benzylbenzamide

SMILES


O=C(NCc1ccccc1)c2ccccc2

Common name


N-benzylbenzamide

IUPAC name


N-benzylbenzamide

SMILES


O=C(NCc1ccccc1)c2ccccc2

INCHI


InChI=1S/C14H13NO/c16-14(13-9-5-2-6-10-13)15-11-12-7-3-1-4-8-12/h1-10H,11H2,(H,15,16)

FORMULA


C14H13NO

Responsive image

Common name


N-benzylbenzamide

IUPAC name


N-benzylbenzamide





Molecular weight


211.259

clogP


2.968

clogS


-3.812

Frequency


0.0007





HBond Acceptor


1

HBond Donor


1

Total Polar
Surface Area


29.1

Number of Rings


2

Rotatable Bond


3

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD00527 Trimethobenzamide Responsive image Antiemetics; Respiratory System; Aminoalkyl Ethers; Antihistamines for Systemic Use; For the treatment of postoperative nausea and vomiting and for nausea associated with gastroenteritis.
FDBD01074 Paclitaxel Responsive image Antineoplastic Agents; Immunosuppressive Agents; Antineoplastic Agents, Phytogenic; Tubulin Modulators; Antineoplastic and Immunomodulating Agents; Taxanes; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C8 Inducers; CYP3A4 Inhibitors; BSEP/ABCB11 Inhibitors; Combined Inhibitors of CYP3A4 and P-glycoprotein; Used in the treatment of Kaposi's sarcoma and cancer of the lung, ovarian, and breast. Abraxane® is specfically indicated for the treatment of metastatic breast cancer and locally advanced or metastatic non-small cell lung cancer.
2 , 1
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
4xx3_ligand_3_1.mol2 4xx3 1 -7.60 C(=O)(NCc1ccccc1)c1ccccc1 16
2igy_ligand_3_48.mol2 2igy 1 -7.54 O=C(NCc1ccccc1)c1ccccc1 16
1g4o_ligand_3_3.mol2 1g4o 1 -6.96 C(NC(=O)c1ccccc1)c1ccccc1 16
1rsd_ligand_3_15.mol2 1rsd 1 -6.91 c1(ccccc1)CNC(=O)c1ccccc1 16
1fd7_ligand_3_16.mol2 1fd7 1 -6.77 c1cc(ccc1)C(=O)NCc1ccccc1 16
4ceb_ligand_3_5.mol2 4ceb 1 -6.68 C(=O)(NCc1ccccc1)c1ccccc1 16
110 , 12